publication venue for
- Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials.. 32:1-15. 2023
- Omaveloxolone: An activator of Nrf2 for the treatment of Friedreich's ataxia.. 32:1-13. 2023
- Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease.. 29:205-208. 2019
- BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.. 28:1031-1040. 2019
- Targeted agents for HER2-positive breast cancer in older adults: current and future perspectives.. 27:787-801. 2018